143 related articles for article (PubMed ID: 33781914)
1. Gene therapy reforms photoreceptor structure and restores vision in NPHP5-associated Leber congenital amaurosis.
Aguirre GD; Cideciyan AV; Dufour VL; Ripolles-García A; Sudharsan R; Swider M; Nikonov R; Iwabe S; Boye SL; Hauswirth WW; Jacobson SG; Beltran WA
Mol Ther; 2021 Aug; 29(8):2456-2468. PubMed ID: 33781914
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of Neurosensory Structure and Function in Animal and Cellular Models of a Congenital Blindness.
Song JY; Aravand P; Nikonov S; Leo L; Lyubarsky A; Bennicelli JL; Pan J; Wei Z; Shpylchak I; Herrera P; Bennett DJ; Commins N; Maguire AM; Pham J; den Hollander AI; Cremers FPM; Koenekoop RK; Roepman R; Nishina P; Zhou S; Pan W; Ying GS; Aleman TS; de Melo J; McNamara I; Sun J; Mills J; Bennett J
Mol Ther; 2018 Jun; 26(6):1581-1593. PubMed ID: 29673930
[TBL] [Abstract][Full Text] [Related]
3. Transient pupillary light reflex in CEP290- or NPHP5-associated Leber congenital amaurosis: Latency as a potential outcome measure of cone function.
Krishnan AK; Jacobson SG; Roman AJ; Iyer BS; Garafalo AV; Héon E; Cideciyan AV
Vision Res; 2020 Mar; 168():53-63. PubMed ID: 32088401
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy Using a miniCEP290 Fragment Delays Photoreceptor Degeneration in a Mouse Model of Leber Congenital Amaurosis.
Zhang W; Li L; Su Q; Gao G; Khanna H
Hum Gene Ther; 2018 Jan; 29(1):42-50. PubMed ID: 28679290
[TBL] [Abstract][Full Text] [Related]
5. In vitro modeling and rescue of ciliopathy associated with IQCB1/NPHP5 mutations using patient-derived cells.
Kruczek K; Qu Z; Welby E; Shimada H; Hiriyanna S; English MA; Zein WM; Brooks BP; Swaroop A
Stem Cell Reports; 2022 Oct; 17(10):2172-2186. PubMed ID: 36084637
[TBL] [Abstract][Full Text] [Related]
6. Deletion of M-Opsin Prevents M Cone Degeneration in a Mouse Model of Leber Congenital Amaurosis.
Xu H; Enemchukwu N; Zhong X; Zhang O; Fu Y
Am J Pathol; 2020 May; 190(5):1059-1067. PubMed ID: 32084365
[TBL] [Abstract][Full Text] [Related]
7. Cone-Driven, Geniculocortical Responses in Canine Models of Outer Retinal Disease.
Taskin HO; Wivel J; Aguirre GD; Beltran WA; Aguirre GK
Transl Vis Sci Technol; 2024 Jan; 13(1):18. PubMed ID: 38241039
[TBL] [Abstract][Full Text] [Related]
8. Gene Augmentation for Autosomal Dominant CRX-Associated Retinopathies.
Sun C; Chen S
Adv Exp Med Biol; 2023; 1415():135-141. PubMed ID: 37440026
[TBL] [Abstract][Full Text] [Related]
9. Let There Be Light: Gene and Cell Therapy for Blindness.
Dalkara D; Goureau O; Marazova K; Sahel JA
Hum Gene Ther; 2016 Feb; 27(2):134-47. PubMed ID: 26751519
[TBL] [Abstract][Full Text] [Related]
10. Retinal degeneration in Aipl1-deficient mice: a new genetic model of Leber congenital amaurosis.
Dyer MA; Donovan SL; Zhang J; Gray J; Ortiz A; Tenney R; Kong J; Allikmets R; Sohocki MM
Brain Res Mol Brain Res; 2004 Dec; 132(2):208-20. PubMed ID: 15582159
[TBL] [Abstract][Full Text] [Related]
11. A mouse model of cone photoreceptor function loss
Naggert ASEN; Collin GB; Wang J; Krebs MP; Chang B
Front Mol Neurosci; 2022; 15():1080136. PubMed ID: 36698779
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Findings, Pathogenic Variants, and Gene Therapy Qualifications Found in a Leber Congenital Amaurosis Phenotypic Spectrum Patient Cohort.
Sather R; Ihinger J; Simmons M; Lobo GP; Montezuma SR
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279252
[TBL] [Abstract][Full Text] [Related]
13. Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives.
Garafalo AV; Cideciyan AV; Héon E; Sheplock R; Pearson A; WeiYang Yu C; Sumaroka A; Aguirre GD; Jacobson SG
Prog Retin Eye Res; 2020 Jul; 77():100827. PubMed ID: 31899291
[TBL] [Abstract][Full Text] [Related]
14. Cone-driven, geniculo-cortical responses in canine models of outer retinal disease.
Taskin HO; Wivel J; Aguirre GD; Beltran WA; Aguirre GK
bioRxiv; 2023 Dec; ():. PubMed ID: 38168165
[TBL] [Abstract][Full Text] [Related]
15. Update on gene therapies in pediatric ophthalmology.
Bremond-Gignac D; Robert MP; Daruich A
Arch Pediatr; 2023 Nov; 30(8S1):8S41-8S45. PubMed ID: 38043982
[TBL] [Abstract][Full Text] [Related]
16. LEBER CONGENITAL AMAUROSIS DUE TO CEP290 MUTATIONS-SEVERE VISION IMPAIRMENT WITH A HIGH UNMET MEDICAL NEED: A Review.
Leroy BP; Birch DG; Duncan JL; Lam BL; Koenekoop RK; Porto FBO; Russell SR; Girach A
Retina; 2021 May; 41(5):898-907. PubMed ID: 33595255
[TBL] [Abstract][Full Text] [Related]
17. Characterization and AAV-mediated
Boon N; Lu X; Andriessen CA; Orlovà M; Quinn PMJ; Boon CJF; Wijnholds J
Mol Ther Methods Clin Dev; 2023 Dec; 31():101128. PubMed ID: 37886604
[TBL] [Abstract][Full Text] [Related]
18. Safety and improved efficacy signals following gene therapy in childhood blindness caused by
Jacobson SG; Cideciyan AV; Ho AC; Peshenko IV; Garafalo AV; Roman AJ; Sumaroka A; Wu V; Krishnan AK; Sheplock R; Boye SL; Dizhoor AM; Boye SE
iScience; 2021 May; 24(5):102409. PubMed ID: 33997691
[TBL] [Abstract][Full Text] [Related]
19. Patient stem cell-derived in vitro disease models for developing novel therapies of retinal ciliopathies.
Kruczek K; Swaroop A
Curr Top Dev Biol; 2023; 155():127-163. PubMed ID: 38043950
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy: perspectives from young adults with Leber's congenital amaurosis.
Napier MP; Selvan K; Hayeems RZ; Shuman C; Chitayat D; Sutherland JE; Day MA; Héon E
Eye (Lond); 2022 Nov; 36(11):2088-2093. PubMed ID: 34531550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
